 |
|
 |
United Kingdom |
|
|
The Pharmaceutical Market: UK
Publication Date January 2007
Publisher Espicom
Product Type Strategic Report
Pages 140
ISBN Number not applicable
Product Code ESP860
|
|
|
Summary
In 2006, the Finnish pharmaceutical market was estimated to be worth US$3.7 billion, equal to 23.4% of healthcare expenditure and 1.9% of estimated GDP. The market is equivalent in size to Argentina, yet is on a par with Switzerland in terms of per capita expenditure. Pharmaceutical per capita expenditure in 2006 is US$699.
The principal regulatory body in Finland is the National Agency for Medicines (NAM), operating under the Ministry for Social Affairs and Health. All pharmaceutical products, available on the domestic market and exported, must receive authorisation from NAM. NAM regulations stipulate conditions on the basis of quality, safety and effectiveness.
The principal authority regarding application for reimbursable status is the Pharmaceutical Pricing Board, affiliated to the Ministry of Social Affairs and Health. Other matters concerning reimbursable status are dealt with by the Social Insurance Institution (SII).
The NAM is viewed as a respected agency in the Mutual Recognition Procedure and is the leading agency in the EU as a reference state in the role of marketing authorisations.
The vast majority of imports are in the form of retail medicaments, accounting for 92.9% of the US$1.7 billion of pharmaceuticals imported from a wide range of countries in 2005. Pharmaceutical exports amounted to US$708 million, indicating that much of the market is import driven.
These in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
|
Content
Background Data
- Geography
- Political Overview
- Economic Overview
- Population
- UK Population, 2001-2005
- Official Population Predictions, 2011 - 2016 (000s)
- Demographic Indicators
- Principal Demographic Indicators by Country/Province, 2002 - 2004
- UK Principal Demographic Indicators, 1998-2004
- Mortality
- UK Causes of Death, 2004
- Causes of Death in England and Wales, 2002-2004
- Cause of Death in Scotland, 2001 - 2004
- Cause of Death in Northern Ireland, 2001 - 2004
- Morbidity
- Reported Infectious Diseases in the UK, 1999-2002
- UK Cancer Incidence by Site, 2002
- HIV & AIDS diagnosis and deaths in the UK 1994-2004
- Charts
- Map of the United Kingdom
- Population by Age Group, 2005 estimate (%)
- Causes of Death in the UK, 2004 (%)
- Chichester, West Sussex, PO20 2FS, United Kingdom
Healthcare System
- Organisation & Administration
- NHS Plan,
- Department of Health (DoH)
- Strategic Health Authorities
- Acute Trusts
- Foundation Trusts
- Care Trusts
- Ambulance Trusts
- Primary Care Trusts
- The NHS Improvement Plan, 2004
- Payment by Results, 2005
- The Healthcare Commission
- National Institute for Health and Clinical Excellence (NICE)
- Health Expenditure
- Total UK Health Expenditure, 1997-2002 ( millions)
- Government Expenditure Plans for the NHS 2004/5 - 2006/7 ( billions)
- Public and Private Health Expenditure, 1997-2002 ( billions)
- Hospital Services
- UK Hospital Beds, 2002/03-2005/
- UK, Average length of stay, 2001 - 2004/05
- Hospital Services in England
- Available Inpatient Beds in NHS Hospitals, 1997/98-2005/06
- Average Daily Number of Available and Occupied Beds by Sector 2005/
- Primary Diagnosis in England by ICD10 Diagnosis Group, 2004/05
- Surgical Procedures in England
- Operations performed in English Hospitals, 2004/
- Hospital Services in Wales
- Wales, Beds and Patient Activity by Broad Specialty, 2005/06
- NHS Wales Beds by Specialty, 2005/06
- Surgical Procedures in Wales
- Selected Surgical Procedures in Wales, 1994/95-1998/99
- Hospital Services in Scotland
- Scotland NHS Available Beds, 2001-2006 (year ending March)
- Provisional Average NHS beds available, Scotland, as of end March 2006
- Scotland, Acute Hospital Discharges, 2001/02 - 2005/06 (Year ending March)
- Surgical Procedures in Scotland
- United Kingdom Healthcare System
- Hospital Operations in Scotland, 2005-2006 (year ending March)
- Hospital Operations in Scotland, as % Day Cases, 2002 - 2006 (year ended March)
- Hospital Services in Northern Ireland
- Bed Availability & Occupancy in Northern Ireland, 1999/2000 - 2004/05
- Inpatient Beds and Activity by Specialty, Northern Ireland, 2005/06
- Surgical Procedures in Northern Ireland
- Use of Operating Theatres in Northern Ireland, 1999/2000 - 2005/06
- Private Hospitals
- Independent Healthcare Groups
- BMI Healthcare
- BUPA
- Capio Healthcare UK (formerly Community Hospitals Group plc)
- Nuffield Hospitals
- HCA International
- Partnership Health Group (PHG)
- Netcare
- NHS Trusts
- Ambulatory Care
- Ambulatory Care in England
- Hospital Ambulatory Attendances in England by Broad Specialty, 1997/98-2004/05 (000s)
- Consultant Ambulatory Attendances in England by Specialty, 2000/01 - 2004/05
- A&E attendances
- Accident & Emergency Attendances in England, 1999/00-2005/
- Ambulatory Care in Wales
- Ambulatory Attendances in Wales by Broad Specialty, 1997/98 - 2005/06 (000s)
- Wales, Ambulatory Attendances by Broad Specialty, 2005/06
- Ambulatory Attendances in Wales by Specialty, 2003/04 - 2005/
- Ambulatory Care in Scotland
- Ambulatory Care in Scotland, 2000-2006
- Ambulatory Activity In Scotland by Specialty, 2006
- Ambulatory Care in Northern Ireland
- Ambulatory Attendances in Northern Ireland, 1998-99 - 2005/06
- Ambulatory Attendances by Specialty, Northern Ireland, 2005/
- Medical Personnel
- UK Physicians by Grade, 1998-2004
- Summary General Practitioners, 1995-2005 (Headcount)
- Dentists, 2005
- Medical Personnel in England
- NHS Hospital, Public Health & Community Health Service Medical/Dental Staff,
- Consultants by Broad Specialty in England, 1993-2005
Healthcare System
-
- NHS Personnel (England) by Broad Specialty, 1997-2002, year ending September, (000s)
- Consultants by Specialty in England, as of 31st March 2005
- Medical Personnel in Wales
- NHS Medical Staff,
- NHS Medical Personnel in Wales, 2000-2005 (Whole time equivilent)
- Hospital Consultants in Wales by Specialty, 1998-2005
- NHS Personnel in Scotland
- NHS Personnel in Scotland, 1999-2005
- Consultants by Specialty in Scotland, 2000 - 2005
- NHS Personnel in Northern Ireland
- Health and Personal Social Services Workforce, 1998-2005
- Medical and Dental Staff by Grade Split, 2005
- Charts
- Public/Private Health Expenditure, 1997-2002 ( billions)
- Admissions by ICD-10 Code, 2005 (%)
- Chichester, West Sussex, PO20 2FS, United Kingdom
- Accessing The Pharmaceutical
- Market
Accessing The Pharmaceutical Market
- Introduction
- Regulatory Environment
- European Union Regulatory Reforms
- Centralised Procedure
- The EMEA
- Mutual Recognition Procedure
- National Procedures
- Medicines & Healthcare products Regulatory Agency (MHRA)
- Pharmaceutical Registration
- Advertising
- Patent Protection & Intellectual Property Rights
- Supplementary Protection Certificates
- Pricing and Reimbursement
- National Institute for Health and Clinical Excellence (NICE)
- Guidelines in development, Appraisals in development, Pharmaceutical Price Regulation Scheme
- Pricing of Generics
- Distribution Channels
- Pharmacy access
- Distributors
- Boots and Alliance UniChem Merger completed
- Hospital Prescribing
- Trade Fairs
- Domestic Production
- UK Pharmaceutical Production, 2001-05 (000s)
- Trade Associations
- ABPI
- BGMA
- PAGB
- Domestic Producers
- AstraZeneca
- Eli Lilly and Company
- GlaxoSmithKline
- Novartis
|
|
|
